利伐沙班用途和效果

Cancer patients have a high incidence of venous thromboembolism (VTE), and VTE is also a common cause of death in cancer patients. Clinical treatment guidelines emphasize that drug anticoagulation is the basic treatment for this type of disease. New oral anticoagulant drugs are reversible direct factor

Rivaroxaban is a direct factor Xa inhibitor. Factor Xa is a key link in the intrinsic and extrinsic coagulation pathways and is the first step in the common coagulation pathway. Activation of each molecule of factor

In phase I and II clinical trials, rivaroxaban can reach maximum plasma concentration 3 to 4 hours after administration of 2.5 to 80.0 mg, and can be administered in multiple doses without accumulating in the body within a reasonable range. Foreign clinical trials on rivaroxaban dose exploration recommend that the starting dose of rivaroxaban treatment is 15 mg, bid, and changed to 20 mg qd after 3 weeks. Maintenance therapy can achieve good results. Multiple clinical studies have shown that rivaroxaban has few interactions with food and drugs after oral administration and does not require laboratory monitoring. It is currently a relatively safe and effective treatment method.

It was officially approved for sale in China in March 2009, and has also been included in the national medical insurance to provide everyone with government discounts to reduce the financial burden. But even after medical insurance, the price of rivaroxaban remains high, prohibiting many families. However, according to what Medical Companion Travel has learned, the most popular one on the market is Germany's Bayer's rivaroxaban, which is priced at only $350 for 20mg*28 tablets. Compared with other versions, this version is more cost-effective and more suitable for long-term use by patients. Since the exchange rate has been in a state of fluctuation for a long time, the price fluctuates with the exchange rate and is not static. For more information about rivaroxaban, please contact Medical Companion Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.